Evolent Health (NYSE:EVH) Coverage Initiated by Analysts at Citigroup

Citigroup started coverage on shares of Evolent Health (NYSE:EVH - Free Report) in a research note published on Monday, Marketbeat.com reports. The brokerage issued a buy rating and a $40.00 price objective on the technology company's stock.

Several other analysts also recently weighed in on the company. JPMorgan Chase & Co. decreased their target price on Evolent Health from $53.00 to $52.00 and set an overweight rating for the company in a research note on Friday, March 15th. JMP Securities raised their price target on shares of Evolent Health from $37.00 to $38.00 and gave the stock a market outperform rating in a research report on Friday, February 23rd. Canaccord Genuity Group cut their price objective on shares of Evolent Health from $45.00 to $44.00 and set a buy rating for the company in a research report on Thursday, March 28th. Barclays started coverage on Evolent Health in a research note on Wednesday, January 3rd. They set an overweight rating and a $39.00 price target on the stock. Finally, William Blair reissued an outperform rating on shares of Evolent Health in a report on Tuesday, January 9th. One research analyst has rated the stock with a sell rating, one has given a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of Moderate Buy and a consensus price target of $42.70.

Evolent Health Stock Up 1.2 %

Shares of NYSE:EVH traded up $0.35 on Monday, reaching $29.86. The company had a trading volume of 638,022 shares, compared to its average volume of 947,107. The stock has a market capitalization of $3.45 billion, a P/E ratio of -23.51 and a beta of 1.54. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.56. The stock has a 50-day moving average price of $31.93 and a 200 day moving average price of $30.26. Evolent Health has a twelve month low of $23.33 and a twelve month high of $36.70.

Evolent Health (NYSE:EVH - Get Free Report) last posted its quarterly earnings data on Thursday, February 22nd. The technology company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.13. The business had revenue of $556.06 million during the quarter, compared to the consensus estimate of $541.87 million. Evolent Health had a negative net margin of 5.76% and a positive return on equity of 6.60%. On average, equities analysts expect that Evolent Health will post 0.87 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in EVH. NBC Securities Inc. increased its position in Evolent Health by 16.6% in the 1st quarter. NBC Securities Inc. now owns 2,461 shares of the technology company's stock valued at $81,000 after acquiring an additional 350 shares in the last quarter. Gamco Investors INC. ET AL raised its position in shares of Evolent Health by 0.5% during the 3rd quarter. Gamco Investors INC. ET AL now owns 97,000 shares of the technology company's stock valued at $2,641,000 after acquiring an additional 500 shares during the last quarter. New York State Common Retirement Fund lifted its stake in shares of Evolent Health by 0.5% in the 3rd quarter. New York State Common Retirement Fund now owns 94,908 shares of the technology company's stock valued at $2,584,000 after purchasing an additional 506 shares during the period. Teacher Retirement System of Texas lifted its stake in shares of Evolent Health by 9.0% in the 3rd quarter. Teacher Retirement System of Texas now owns 8,293 shares of the technology company's stock valued at $226,000 after purchasing an additional 685 shares during the period. Finally, Genesee Capital Advisors LLC boosted its position in shares of Evolent Health by 2.2% in the 4th quarter. Genesee Capital Advisors LLC now owns 38,390 shares of the technology company's stock worth $1,268,000 after purchasing an additional 825 shares during the last quarter.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.